Janet Freeman-Daily, MS, ENG, is a metastatic lung cancer patient who was diagnosed with stage 3A NSCLC in May 2011. After two chemotherapy regimes, two radiation protocols, and two recurrences, she used information obtained in online forums to get her tumor tissue tested for newer molecular markers and find a clinical trial. She has had No Evidence of Disease since January 2013 thanks to precision medicine and targeted therapy. After applying her MIT and Caltech engineering degrees to a career in aerospace systems engineering for two decades, she now is an active advocate for lung cancer patients, employing her writing and speaking skills and science background to translate the experience and science of lung cancer treatment and research into language other patients can understand. Her advocacy accomplishments include an award-winning lung cancer blog at grayconnections.net, contributing blogger for CURE Today magazine, co-moderator for Lung Cancer Social Media (#LCSM) Chat on Twitter, participant in President’s Cancer Panel workshops, Consumer Reviewer for the DoD’s Lung Cancer Research Program (LCRP), patient advocate on the Lung Cancer SPORE at University of Colorado Cancer Center, ePatient Scholar Presenter at the 2014 Stanford Medicine X Conference, and invited speaker at oncology conferences.